Category: Moms

Hyperglycemia and inflammation

Hyperglycemia and inflammation

Sign In. Current anti-inflammatory, statin, and estrogen use were Hyperglycemiw at Hyperglycemia and inflammation clinic visit. Hyperglycemia and inflammation Weight management techniques Is Available To Hypergpycemia Only Imflammation In or Infla,mation an Account. Macrophages, inflammation, and insulin resistance. Surgical Cervical Vagotomy VGX A ventral incision on the neck was performed to retract the sternocleidomastoid muscle and to visualize the carotid artery and vagus nerves. Zhang F, Chen Y, Heiman M, Dimarchi R. Control animals underwent sham surgery without the electrical stimulation.

Hyperglycemia and inflammation -

Administration of glucose decreased serum TNF levels through the vagus nerve, as it was prevented by surgical vagotomy Fig.

We previously reported that vagal electrical stimulation attenuates serum TNF levels in endotoxemic mice by inhibiting its production in the spleen 23 , 24 , Thus, we analyzed whether glucose induces a similar mechanism mediated by the spleen. Administration of glucose attenuated serum TNF levels in sham but not in splenectomized mice Fig.

These results indicate that glucose activates the vagus nerve to attenuate splenic and serum TNF levels in endotoxemia. Glucose activates the vagus nerve. b Fasted animals received saline solution with glucose 0, 0. The previous studies on vagal modulation focused on TNF regulation during endotoxemia 23 , 24 , Here, we analyzed whether vagal stimulation attenuates hyperglycemia.

Vagal electrical stimulation significantly attenuated hyperglycemic responses to bacterial endotoxin Fig. Previous studies reported the potential of vagal stimulation to attenuate serum TNF levels 25 , 26 , 27 , However, these cytokines are produced after the hyperglycemic peak, and thus we focused on the relationship between vagal modulation of hyperglycemic and TNF and whether the vagus nerve controls hyperglycemia by regulating TNF.

As we previously reported that splenectomy abrogated vagal control of TNF, we analyzed whether splenectomy also prevents vagal modulation of hyperglycemia. Vagal electrical stimulation attenuated serum TNF levels in sham but not in splenectomized mice Fig.

By contrast, vagal electrical stimulation attenuated hyperglycemia in both sham and splenectomized mice Fig. Next, we wondered whether the vagus nerve controls hyperglycemia by inducing insulin.

Vagal stimulation increased serum insulin levels Fig. We further confirmed our results in pancreatectomized mice. Vagal stimulation induced insulin in sham but not in pancreatectomized mice Fig.

Likewise, vagal stimulation attenuated hyperglycemia in sham but not in pancreatectomized mice Fig. These results show that vagal stimulation can attenuate hyperglycemia in endotoxemia by inducing insulin. Vagal stimulation attenuates hyperglycemia by inducing insulin. Blood glucose levels were analyzed at different time points.

b , c Mice underwent sham or surgical splenectomy SPX 3 days before LPS. Animals underwent control surgery or vagal stimulation VS , and serum TNF at 1.

d Fasted mice received sham or vagal stimulation VS , and serum insulin levels were analyzed at the indicated time points. Next, we analyzed how the vagus nerve induces insulin.

These results concur with other studies showing that innervations of the adrenal glands modulate hyperglycemia in hemorrhagic shock 35 , Thus, we analyzed whether vagal stimulation attenuates hyperglycemia in adrenalectomized endotoxemic mice.

Vagal stimulation attenuated hyperglycemia by around 2-fold in sham but not in adrenalectomized mice Fig. Next, we analyzed whether vagal stimulation induces the production of catecholamines in the adrenal glands.

Vagal stimulation induced the production of the three catecholamines: dopamine, norepinephrine, and epinephrine, but the most significant effect was the increase in blood dopamine levels Fig.

Conversely, the most significant effect of adrenalectomy was to attenuate the vagal induction of dopamine Fig. Thus, we analyzed the potential of dopamine to attenuate hyperglycemia in endotoxemia.

Treatment with dopamine attenuated hyperglycemia in endotoxemic mice Fig. Given that dopamine has a short chemical half-life span limiting its clinical potential, we analyzed whether fenoldopam, a well-known stable specific agonist for D1-like dopaminergic receptors 37 , 38 , mimics the potential of dopamine to attenuate hyperglycemia.

Fenoldopam was more effective than dopamine at inhibiting hyperglycemia in endotoxemia Fig. Fenoldopam was also more effective than dopamine at attenuating serum TNF levels Fig.

These results show the potential of dopaminergic agonists to modulate both hyperglycemic and inflammatory responses to bacterial endotoxin. Dopamine controls hyperglycemia in experimental sepsis.

a — c Fasted animals underwent a sham or a , c surgical adrenalectomy ADX 3 days before LPS. a Blood glucose or b , c catecholamines dopamine DA , norepinephrine NE or epinephrine E were analyzed at 1. d , e Blood glucose and f serum TNF levels were analyzed at the indicated time points.

Blood glucose g and TNF h were analyzed at the indicated time points. We previously reported that the induction of diabetes with streptozotocin, the standard method to induce experimental diabetes in mice, increases hyperglycemic and inflammatory responses to bacterial endotoxin and worsens survival in endotoxemic mice Thus, we analyzed whether fenoldopam attenuates hyperglycemia in experimental sepsis with diabetes.

Time-course experiments indicated that treatment with fenoldopam significantly attenuates hyperglycemia in endotoxemic diabetic mice from 0. These time-course analyses show that fenoldopam inhibited and did not merely delay hyperglycemia or TNF production in endotoxemic mice with diabetes. These results suggest that dopaminergic agonist type 1, such a fenoldopam may attenuate hyperglycemia and inflammation in both normal and diabetic endotoxemic mice.

Our results indicate that metabolic fasting affects both hyperglycemic and systemic inflammatory responses to bacterial endotoxin by modulating vagal neuromodulation. Fasted animals had worse systemic inflammation, organ function, and survival in experimental sepsis.

Thus, we analyzed the relationship between glycemia and the inflammatory response to bacterial endotoxin. Experimental and clinical studies have shown that sepsis is characterized by an initial hyperglycemic response followed by a hypoglycemic phase and both phases contribute to the pathogenesis and prognosis of sepsis 12 , 13 , 14 , 15 , Thus, we focused on the initial hyperglycemic response and whether they determine the production of inflammatory factors.

Indeed, administration of glucose activated vagal electric potential and attenuated serum TNF levels in sham but not in vagotomized mice. Although the molecular mechanisms of vagal activation by hyperglycemia are unknown, recent studies show that glucose activates specific neuronal networks in central regions that modulate vagal activity.

These neurons can activate different neuronal networks with specific implications. For instance, defective autophagy in POMC neurons leads to glucose intolerance and obesity 47 , 48 , whereas disrupted autophagy in glucose-sensing AgRP neurons promotes leanness and reduces food intake 49 , Although recent studies suggested that glucose transporters and hexokinase can contribute to neuronal activation by glucose, the molecular mechanisms are not well-known 51 , 52 , Furthermore, glucose can also activate astrocytes, which in turn can activate central neuronal networks through the astrocyte-neuron lactate shuttle 46 and the neuronal pyruvate metabolism These studies focused on the potential of glucose to activate central neuronal networks that regulate energy homeostasis and hyperglycemia.

Our results now warrant similar studies to determine the specific neurons and networks activated by glucose to induce vagal control of hyperglycemia and inflammation in infectious disorders. Future studies will also determine how these networks may link metabolic and immunological disorders and their contribution to inflammatory or infectious disorders such as sepsis.

Administration of glucose activated vagal electrical potential without affecting arterial blood pressure. Semapimod also activated vagal electrical potential and attenuated serum TNF levels in endotoxemia without affecting arterial blood pressure Likewise, melanocortin peptides, cholecystokinin, ghrelin, and leptin can also activate the vagus nerve to control physiological homeostasis 55 , 56 , These mechanisms of vagal activation have multiple clinical implications.

For instance, deletion of leptin-induced vagal activation causes hyperphagia, obesity, diabetes, and infertility 56 , Although these studies focused on vagal regulation of serum TNF levels, our present study now suggests that vagal regulation of hyperglycemia can also contribute to the effects of the vagus nerve in these conditions.

In line with the hypothesis, our recent clinical study shows that neuronal stimulation can improve postoperative recovery by preventing hyperglycemia Our results indicate that efferent vagal stimulation attenuates hyperglycemia in endotoxemia by inducing insulin and regardless of TNF regulation.

Although neuronal regulation of insulin secretion is a complex process depending on the physiological conditions, our results concur with previous studies indicating that the vagus nerve can modulate cephalic and postprandial insulin secretion 29 , 30 , From a clinical perspective, patients with complete resection of the subdiaphragmatic vagus nerve can display a longer periodicity of plasma insulin oscillations Clinical studies on patients with subdiaphragmatic vagotomy also indicate that truncal vagotomy decreases the glucagon response to insulin hypoglycemia as compared to selective vagotomy 66 , and abdominal vagal blocking decreases pancreatic exocrine secretion in the animal model Furthermore, recent studies indicate that vagal blocking can improve glycemic control and blood pressure in obese patients with type 2 diabetes mellitus In agreement with these results, previous physiological studies showed that innervations of the adrenal glands modulate hyperglycemia in hemorrhagic shock 35 , Our current results show that efferent vagal stimulation induced insulin and adrenalectomy prevented vagal control of hyperglycemia in endotoxemia.

Our study shows that vagal stimulation induces the production of dopamine from the adrenal glands. Administration of dopamine decreased hyperglycemia and serum TNF levels in endotoxemia.

These results concur with clinical studies showing that dopamine can restore tissue perfusion in septic shock and critically ill patients 69 , However, dopamine can also increase the risk of tachyarrhythmia 69 , 70 and worsens survival in septic animals We hypothesized that selective dopaminergic agonists may avoid unspecific side effects of dopamine.

Dopaminergic receptors are classified into D1-like D1R, D5R or D2-like D2R, D3R, D4R receptors that signal through Gαs or Gαi proteins, respectively. Fenoldopam is a well-characterized, stable and specific agonist with ~fold greater affinity for D1Rs than dopamine 35 , 36 , 37 , Fenoldopam was more effective than dopamine at controlling hyperglycemia and TNF production in endotoxemic mice.

We previously reported that experimental diabetes increases hyperglycemic and inflammatory responses to bacterial endotoxin and worsens survival in endotoxemic mice Our present results also suggest that fenoldopam attenuates hyperglycemia before the serum TNF peak at 1.

Future studies will be required to determine whether fenoldopam control of hyperglycemia contributes to modulate serum TNF levels. By comparison, inhibition of TNF by using neutralizing anti-TNF antibodies increased the mortality when administered after the septic challenge in normal mice 9.

These studies of neuromodulation are allowing the design of novel treatments for infectious and inflammatory disorders.

The study of the sympathetic baroreflex system allowed the design of selective beta-blockers for hypertension and arrhythmia. Similar studies are now required to determine whether specific dopaminergic agonists may provide therapeutic advantages for hyperglycemia and inflammation in septic patients with preexisting metabolic conditions such as diabetes.

LPS E. Coli B4 , dopamine hydrochloride, fenoldopam, streptozotocin, and glucose were purchased from Sigma-Aldrich® Saint Louis, MO.

The glucose measuring strips were purchased from PharmaTech Solutions, Inc Westlake Village, CA. Pentobarbital sodium was purchased from Diamondback Scottsdale, AZ ; ketamine from Henry Schein animal health Dublin, OH ; xylazine from Akron animal health Lake Forest, IL, USA and enrofloxacin from Bayer Healthcare Shawnee Mission, KS, USA.

Mice were fed standard chow diet Louis, MO. The investigators analyzing the samples were blinded to the treatments. and vagal surgeries performed as we described Surgical Cervical Vagotomy VGX A ventral incision on the neck was performed to retract the sternocleidomastoid muscle and to visualize the carotid artery and vagus nerves.

The vagal trunks were ligated with size 4—0 silk and sectioned. Vagal Stimulation VS The right cervical vagal trunk was isolated and connected to the platinum electrode. Control animals underwent sham surgery without the electrical stimulation.

Vagal activity recording was performed as described Anesthetized Wistar rats received ventral neck incision to connect the vagus nerve to the electrode. Then, the carotid artery and femoral vein were catheterized for recording pulsatile arterial pressure and for glucose administration iv , respectively.

Animals were allowed to recover consciousness after surgery. The arterial catheter was connected to a pressure transducer MLT and the signal was amplified by ML ADInstruments, Bella Vista, Australia and sampled in the oscilloscope Tektronics Anesthesia was confirmed by the absence of withdrawal reflex to toe pinch.

Antibiotics Enrofloxacine 2. Splenectomy: was performed 3 days prior to the experiment as we described in J Exp Med Animals underwent an abdominal incision to expose the spleen.

The three main branches of the splenic artery were stabilized with nylon thread, ligated and cut. The spleen was removed and the wound was closed with sutures with catgut for the abdominal wall, and nylon thread for the skin. Adrenalectomy: was performed as described Animals received a dorsal incision from the first to the third lumbar vertebrae.

The latissimus dorsi muscle was retracted and both adrenal glands and their adipose tissue were removed. Pancreatectomy : was performed similarly to that previously described TNF, IL6, IL10, TGFβ1 and IFNγ were analyzed with the respective ELISA kit Affymettrix Inc, San Diego, CA.

Serum HMGB1 was analyzed using HMGB1 detection ELISA kit Chondrex Inc. Blood catecholamines were analyzed by ELISA LDN immunoassays and services, Germany at 1.

Glucose was analyzed from the mouse tail tip blood using the Genstrip PharmaTech Solutions Inc. Serum insulin was analyzed with the Mercodia mouse insulin ELISA kit, Mercodia AB, Uppsala, Sweden. Tests were performed with GraphPad Prism Software® GraphPad Software, La Jolla, CA. The sample size was determined with power analyses of our previous studies 25 , Analyses of three or more groups were performed with one-way ANOVA with multiple pair-wise comparisons.

The time courses and pair-wise comparisons were analyzed with the two-way ANOVA for repeated measures. Normality and homogeneity of variance were confirmed with Kolmogorov-Smirnov analyses. Survival was analyzed with the Log-rank Mantel-Cox test.

Angus, D. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine 29 , — Article CAS Google Scholar.

Hotchkiss, R. The pathophysiology and treatment of sepsis. The New England journal of medicine , — Ulloa, L. Trends Mol Med 11 , 56—63 Rice, T.

Therapeutic intervention and targets for sepsis. Annu Rev Med 56 , — Martin, G. The epidemiology of sepsis in the United States from through Article Google Scholar. Tracey, K. Nature , — Article CAS ADS Google Scholar. Marshall, J.

Why have clinical trials in sepsis failed? Trends Mol Med 20 , — Carré, J. Cellular energetic metabolism in sepsis: The need for a systems approach. Biochimica et Biophysica Acta BBA - Bioenergetics , — Eskandari, M. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.

J Immunol , — CAS PubMed Google Scholar. Brealey, D. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet London, England , — Wolfe, R. Energy metabolism in trauma and sepsis: the role of fat.

Progress in clinical and biological research , 89— Machado, F. The epidemiology of sepsis in Brazilian intensive care units the Sepsis PREvalence Assessment Database, SPREAD : an observational study.

The Lancet Infectious Diseases 17 , — Cerra, F. Hypermetabolism-organ failure syndrome: a metabolic response to injury. Critical care clinics 5 , — van Vught, L. Diabetes Is Not Associated With Increased Day Mortality Risk in Critically Ill Patients With Sepsis.

Critical care medicine 45 , e—e Finfer, S. Intensive versus conventional glucose control in critically ill patients. Novosad, S. Vital Signs: Epidemiology of Sepsis: Prevalence of Health Care Factors and Opportunities for Prevention.

MMWR Morb Mortal Wkly Rep 65 , — Kosteli, A. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. The findings from the Third National Health and Nutrition Examination Survey showed a higher prevalence of increased levels of CRP in both overweight and obese participants Adiposity, in particular visceral adipose tissue, has been found to be a key promoter of low-grade chronic inflammation 28 , Obesity appears to be a state of chronic inflammation with increased production of cytokines and other acute-phase reactants that play a crucial role in regulation of systemic insulin action; it has been shown that TNF-α—deficient mice show increased insulin action Is the elevation of inflammatory markers the result of vascular and renal disease due to diabetes or a causal pathway?

Numerous studies showed an association between cardiovascular diseases with inflammation, and a higher CRP level is associated with increased risk of development of vascular disease 31 — CRP and IL-6 are also known to increase with declining kidney function, even before end-stage renal disease occurs 35 — Trials to study decreases of inflammation in diabetes or cardiovascular disease events are still lacking.

A better understanding of the actions of cytokines with other factors in the pathogenesis of diabetes may lead to improved understanding of its cause and open new approaches for its prevention. We found an association between poor glycemic control and an increased level of CRP. Several studies showed that cytokine levels CRP, IL-6, and TNF-α are related to glycemic control 38 — Improvement of glycemic control has an inconsistent beneficial impact on the level of inflammatory markers.

No significant effect was found on the levels of IL-6 and TNF-α with sulfonylureas or insulin therapy, but a significant decrease in CRP was observed with insulin Troglitazone with an improvement in glycemic control reduces CRP 42 and decreases plasma levels of TNF-α in obese diabetic patients One weight loss study showed that moderate-intensity regular exercise decreases the TNF-α level A high inflammation level might contribute to the worsening of progression of type 2 diabetes in addition to glycemic control.

Our study has several strengths. First, we have several measures of inflammatory markers and can create an inflammatory index. Second, the study includes a large sample size and a biracial population with a high percentage of blacks.

One limitation of our study is that because of the study design cross-sectional study , the direction of these associations cannot be conclusively determined and a causal relationship cannot be inferred. Additionally, the study population includes well-functioning relatively healthy participants; our findings may not be generalized to a frail older population.

Among those with diabetes, poorer glycemic control was associated with higher levels of CRP. Whether baseline levels of inflammatory markers in those without pre-diabetes or diabetes would be predictors of the onset of pre-diabetes and diabetes should be determined, and we plan to explore this in our longitudinal data.

Plasma levels of inflammatory markers of the diabetic and the hyperglycemic groups compared with the NGT group.

For risk of high inflammation level associated with diabetes and hyperglycemic status, model 1 is adjusted on age, sex, race, smoking status, alcohol intake, education, and site.

Model 2 adds total body fat, visceral fat, and height. Model 3 adds cardiovascular diseases, hypertension, peripheral arterial disease, renal insufficiency, arthritis, pulmonary disease, anti-inflammatory, statin, and estrogen use. For relationship between glycemic control and inflammation in diabetes, models 1 and 2 are the same and model 3 adds diabetes duration.

This study was supported by Contracts NAG, NAG, and NAG from the National Institute on Aging. This research was supported in part by the Intramural Research Program of National Institutes of Health, National Institute on Aging.

A table elsewhere in this issue shows conventional and Système International SI units and conversion factors for many substances. Sign In or Create an Account. Search Dropdown Menu. header search search input Search input auto suggest. filter your search All Content All Journals Diabetes Care.

Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 29, Issue 8. Previous Article Next Article.

RESEARCH DESIGN AND METHODS. Article Information. Article Navigation. Cardiovascular and Metabolic Risk August 01 Diabetes, Hyperglycemia, and Inflammation in Older Individuals : The Health, Aging and Body Composition study Nathalie de Rekeneire, MD, MS ; Nathalie de Rekeneire, MD, MS.

This Site. Google Scholar. Rita Peila, PHD ; Rita Peila, PHD. Jingzhong Ding, PHD ; Jingzhong Ding, PHD. Lisa H. Colbert, PHD ; Lisa H.

Colbert, PHD. Marjolein Visser, PHD ; Marjolein Visser, PHD. Ronald I. Shorr, MD, MS ; Ronald I. Shorr, MD, MS. Stephen B. Kritchevsky, PHD ; Stephen B.

Kritchevsky, PHD. Lewis H. Kuller, MD, DRPH ; Lewis H. Kuller, MD, DRPH. Elsa S. Strotmeyer, PHD ; Elsa S. Strotmeyer, PHD. Ann V. Schwartz, PHD ; Ann V. Schwartz, PHD. Bruno Vellas, MD, PHD ; Bruno Vellas, MD, PHD.

Tamara B. Harris, MD, MS Tamara B. Harris, MD, MS. Address correspondence and reprint requests to Nathalie de Rekeneire, MD, Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, Gateway Building, Suite 3C, Wisconsin Ave. E-mail: rekenein nia. Diabetes Care ;29 8 — Article history Received:.

Get Permissions. toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest. Table 1— Baseline characteristics by diabetes and hyperglycemic status. Data are means ± SD or median interquartile range unless otherwise noted.

DXA, dual-energy X-ray absorptiometry. View Large. Table 2— Plasma levels of inflammatory markers of the diabetic and the hyperglycemic groups compared with the NGT group. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Watanabe S, Alexander M, Misharin AV, Budinger GRS. The role of macrophages in the resolution of inflammation. J Clin Invest 7 — doi: PubMed Abstract CrossRef Full Text Google Scholar. Wang Y, Smith W, Hao D, He B, Kong L.

M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds. Int Immunopharmacol — Thapa B, Lee K. Metabolic influence on macrophage polarization and pathogenesis. BMB Rep 52 6 — Martin KE, García AJ.

Macrophage phenotypes in tissue repair and the foreign body response: Implications for biomaterial-based regenerative medicine strategies. Acta Biomater — Locati M, Curtale G, Mantovani A.

Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol — Germic N, Frangez Z, Yousefi S, Simon HU. Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation.

Cell Death Differ 26 4 — Jung S, Jeong H, Yu SW. Autophagy as a decisive process for cell death. Exp Mol Med 52 6 — Wang Y, Li YB, Yin JJ, Wang Y, Zhu LB, Xie GY, et al. Autophagy regulates inflammation following oxidative injury in diabetes.

Autophagy 9 3 —7. Klionsky DJ. Stepping back from the guidelines: Where do we stand? Autophagy 12 2 —4. Jiang GM, Tan Y, Wang H, Peng L, Chen HT, Meng XJ, et al.

The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Mol Cancer 18 1 Deretic V, Kimura T, Timmins G, Moseley P, Chauhan S, Mandell M.

Immunologic manifestations of autophagy. J Clin Invest 1 — Cadwell K. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis.

Nat Rev Immunol 16 11 — Deretic V, Levine B. Autophagy balances inflammation in innate immunity. Autophagy 14 2 — Yin X, Xin H, Mao S, Wu G, Guo L. The role of autophagy in sepsis: Protection and injury to organs.

Front Physiol Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev 22 4 — Kaushik V, Yakisich JS, Kumar A, Azad N, Iyer AKV.

Ionophores: Potential use as anticancer drugs and chemosensitizers. Cancers Basel 10 10 Gao G, Liu F, Xu Z, Wan D, Han Y, Kuang Y, et al. Evidence of nigericin as a potential therapeutic candidate for cancers: A review. BioMed Pharmacother Wang RC, Wei Y, An Z, Zou Z, Xiao G, Bhagat G, et al.

Akt-mediated regulation of autophagy and tumorigenesis through beclin 1 phosphorylation. Science —9. Yoshii SR, Mizushima N. Monitoring and measuring autophagy. Int J Mol Sci 18 9 Qiu P, Liu Y, Zhang J. Review: the role and mechanisms of macrophage autophagy in sepsis.

Inflammation 42 1 :6— Biasizzo M, Kopitar-Jerala N. Interplay between NLRP3 inflammasome and autophagy. Front Immunol Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44 3 — Kaneko N, Kurata M, Yamamoto T, Morikawa S, Masumoto J.

The role of interleukin-1 in general pathology. Inflammation Regen CrossRef Full Text Google Scholar. Xiu F, Stanojcic M, Diao L, Jeschke MG. Stress hyperglycemia, insulin treatment, and innate immune cells. Int J Endocrinol Pavlou S, Lindsay J, Ingram R, Xu H, Chen M.

Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity. BMC Immunol 19 1 Edgar L, Akbar N, Braithwaite AT, Krausgruber T, Gallart-Ayala H, Bailey J, et al. Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis.

Circulation 12 — Fiorentino TV, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.

Curr Pharm Des 19 32 — Yan LJ. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. J Diabetes Res Ighodaro OM.

Molecular pathways associated with oxidative stress in diabetes mellitus. BioMed Pharmacother — Ayala TS, Tessaro FHG, Jannuzzi GP, Bella LM, Ferreira KS, Martins JO.

Nathalie anv RekeneireHyperglycemia and inflammation Peila inflammatoon, Jingzhong DingLisa H. ColbertMarjolein VisserRonald I. ShorrStephen B. KritchevskyLewis H. KullerElsa S. StrotmeyerAnn V. Hhperglycemia Hyperglycemia and inflammation. Ultimate Guide. Inflammation helps heal your body, but chronic inflammation can cause serious damage. Esti Schabelman, MD. You can get an Hypfrglycemia response to an injury like a cut or a splinterto an infection from bacteria or a virus, or from other exposures that the body may see as a threat, such as stressdietary sugarand environmental toxins. Inflammation is usually divided into two types: acute and chronic. Hyperglycemia and inflammation

Video

Glucocorticoids - Anti-Inflammation, Mechanism of Action

Hyperglycemia and inflammation -

Changes in your diet are among the easiest ways to decrease inflammation. Avoid refined carbohydrates, sugary beverages, and other foods that cause spikes in your blood glucose levels.

Instead, increase your consumption of fiber, fruits, vegetables, nuts, seeds, and other low-glycemic-index foods , all of which may help lower your risks of cardiovascular disease and diabetes. The plant chemicals called polyphenols in green and black teas have been shown to lower levels of inflammatory markers, like CRP.

Curcumin, present in turmeric , has been shown to help with inflammation in animal studies. You already know that exercise, especially moderate intensity exercise , can help with weight loss—but it may also decrease the levels of proinflammatory chemicals in your body, regardless of how much weight you lose.

Smoking and stress are two other factors that can increase inflammation. However, it can also wreak havoc in your body if left unchecked, especially over the long run.

Positive lifestyle choices that limit inflammation can go a long way toward keeping your body healthy. Why are antioxidants good for you? They reduce oxidative stress, a condition of electron imbalance in your cells that underlies metabolic dysfunction.

Emma Betuel. Casey Means, MD. Metabolic Basics. Glucose is a simple carbohydrate, a monosaccharide, which means it is a single sugar.

We get glucose from the food we eat. Mike Haney. Mental Health. Evidence is clear that SARS-CoV-2 can trigger blood sugar problems, even in people without diabetes, and that high glucose worsens COVID outcomes. Kristen Mascia. Ami Kapadia. Omega-3 fatty acids improve cellular health, help reduce inflammation and promote metabolic health.

Here's the science behind them and how you can get more. Kaitlin Sullivan. Rich Joseph, MD. The glycemic index provides insight into how particular foods affect glucose but has limitations.

Stephanie Eckelkamp. The Explainer. Being aware of these causes of inaccurate data can help you identify—and avoid—surprising and misleading feedback. Joy Manning, RD.

Inside Levels. Levels Co-Founder's new book—Good Energy: The Surprising Connection Between Metabolism and Limitless Health—releases May 14; available for pre-order today. The Levels Team. Metabolic flexibility means that your body can switch easily between burning glucose and fat, which means you have better energy and endurance.

Jennifer Chesak. Dominic D'Agostino, PhD. Inflammation and glucose levels: How high blood sugar can turn a good system bad. Written By Esti Schabelman, MD.

Article highlights Inflammation is a natural defense system in which your body attacks something it sees as a harm, such as a cut, an infection or even stress. That response produces symptoms like redness, pain, swelling, warmth, and loss of function.

Chronic inflammation can increase your risk of heart attack, obesity, cancer and diabetes, among other conditions. High blood sugar, or hyperglycemia, and the insulin resistance that often accompanies it, can be proinflammatory.

A healthy diet and lifestyle can greatly reduce your chance of chronic inflammation. Get updates, new articles, exclusive discounts, and more. Email Required. This field is for validation purposes and should be left unchanged. More Ultimate Guides.

Metabolic Basics Ultimate Guide What is oxidative stress and why does it matter to metabolic health? Metabolic Basics Ultimate Guide What is Glucose? Mental Health Ultimate Guide Why glucose matters to COVID outcomes Evidence is clear that SARS-CoV-2 can trigger blood sugar problems, even in people without diabetes, and that high glucose worsens COVID outcomes.

Nutrition Ultimate Guide Why omega 3s are crucial to strong metabolic health Omega-3 fatty acids improve cellular health, help reduce inflammation and promote metabolic health. The Latest From Levels. Nutrition Ultimate Guide Is the glycemic index useful?

Metabolic Basics The Explainer 7 things that can falsely impact glucose readings Being aware of these causes of inaccurate data can help you identify—and avoid—surprising and misleading feedback. Inside Levels Announcement Announcing: Dr. Cytokine Growth Factor Rev 22 4 — Kaushik V, Yakisich JS, Kumar A, Azad N, Iyer AKV.

Ionophores: Potential use as anticancer drugs and chemosensitizers. Cancers Basel 10 10 Gao G, Liu F, Xu Z, Wan D, Han Y, Kuang Y, et al.

Evidence of nigericin as a potential therapeutic candidate for cancers: A review. BioMed Pharmacother Wang RC, Wei Y, An Z, Zou Z, Xiao G, Bhagat G, et al. Akt-mediated regulation of autophagy and tumorigenesis through beclin 1 phosphorylation.

Science —9. Yoshii SR, Mizushima N. Monitoring and measuring autophagy. Int J Mol Sci 18 9 Qiu P, Liu Y, Zhang J. Review: the role and mechanisms of macrophage autophagy in sepsis.

Inflammation 42 1 :6— Biasizzo M, Kopitar-Jerala N. Interplay between NLRP3 inflammasome and autophagy. Front Immunol Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44 3 — Kaneko N, Kurata M, Yamamoto T, Morikawa S, Masumoto J.

The role of interleukin-1 in general pathology. Inflammation Regen CrossRef Full Text Google Scholar. Xiu F, Stanojcic M, Diao L, Jeschke MG.

Stress hyperglycemia, insulin treatment, and innate immune cells. Int J Endocrinol Pavlou S, Lindsay J, Ingram R, Xu H, Chen M. Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity.

BMC Immunol 19 1 Edgar L, Akbar N, Braithwaite AT, Krausgruber T, Gallart-Ayala H, Bailey J, et al. Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis.

Circulation 12 — Fiorentino TV, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des 19 32 — Yan LJ. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress.

J Diabetes Res Ighodaro OM. Molecular pathways associated with oxidative stress in diabetes mellitus.

BioMed Pharmacother — Ayala TS, Tessaro FHG, Jannuzzi GP, Bella LM, Ferreira KS, Martins JO. High glucose environments interfere with bone marrow-derived macrophage inflammatory mediator release, the TLR4 pathway and glucose metabolism. Sci Rep 9 1 Marim FM, Silveira TN, Lima DS Jr, Zamboni DS.

A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PloS One 5 12 :e Carlos D, Costa FR, Pereira CA, Rocha FA, Yaochite JN, Oliveira GG, et al.

Mitochondrial DNA activates the NLRP3 inflammasome and predisposes to type 1 diabetes in murine model.

Ramalho T, Filgueiras L, Silva-Jr IA, Pessoa AFM, Jancar S. Impaired wound healing in type 1 diabetes is dependent on 5-lipoxygenase products. Sci Rep 8 1 Pan Y, Wang Y, Cai L, Cai Y, Hu J, Yu C, et al. Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats.

Br J Pharmacol 3 — Torres-Castro I, Arroyo-Camarena ÚD, Martínez-Reyes CP, Gómez-Arauz AY, Dueñas-Andrade Y, Hernández-Ruiz J, et al. Human monocytes and macrophages undergo M1-type inflammatory polarization in response to high levels of glucose.

Immunol Lett —9. Cheng CI, Chen PH, Lin YC, Kao YH. High glucose activates Raw Cell Signal 27 2 — Tessaro GFH, Ayala TS, Bella LM, Martins JO. Immunobiology 2 Lachmandas E, Vrieling F, Wilson LG, Joosten SA, Netea MG, Ottenhoff TH, et al. The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with mycobacterium tuberculosis.

PloS One 10 2 :e Park EY, Park JB. High glucose-induced oxidative stress promotes autophagy through mitochondrial damage in rat notochordal cells.

Int Orthop 37 12 — Ma T, Zhu J, Chen X, Zha D, Singhal PC, Ding G. High glucose induces autophagy in podocytes. Exp Cell Res 6 — Rendra E, Riabov V, Mossel DM, Sevastyanova T, Harmsen MC, Kzhyshkowska J.

Reactive oxygen species ROS in macrophage activation and function in diabetes. Immunobiology 2 — Padman BS, Nguyen TN, Uoselis L, Skulsuppaisarn M, Nguyen LK, Lazarou M. Nat Commun 10 1 Bharath LP, Rockhold JD, Conway R. Selective autophagy in hyperglycemia-induced microvascular and macrovascular diseases.

Cells 10 8 Cao Y, Luo Y, Zou J, Ouyang J, Cai Z, Zeng X, et al. Autophagy and its role in gastric cancer. Clin Chim Acta — Feng Y, Liu B, Zheng X, Chen L, Chen W, Fang Z. The protective role of autophagy in sepsis. Microb Pathog — Darios F, Stevanin G. Impairment of lysosome function and autophagy in rare neurodegenerative diseases.

J Mol Biol 8 — Painter JD, Galle-Treger L, Akbari O. Role of autophagy in lung inflammation. Dai J, Zhang X, Li L, Chen H, Chai Y. Autophagy inhibition contributes to ROS-producing NLRP3-dependent inflammasome activation and cytokine secretion in high glucose-induced macrophages.

Cell Physiol Biochem 43 1 — Racanelli AC, Kikkers SA, Choi AMK, Cloonan SM. Autophagy and inflammation in chronic respiratory disease. Sunahara KK, Nunes FP, Baptista MA, Strell C, Sannomiya P, Westerberg LS, et al.

Insulin influences autophagy response distinctively in macrophages of different compartments. Cell Physiol Biochem 34 6 — Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int J Mol Sci 20 13 Harris J, Lang T, Thomas JPW, Sukkar MB, Nabar NR, Kehrl JH.

Autophagy and inflammasomes. Mol Immunol —5. Shi H, Zhang Z, Wang X, Li R, Hou W, Bi W, et al. Inhibition of autophagy induces IL-1β release from ARPE cells via ROS mediated NLRP3 inflammasome activation under high glucose stress.

Biochem Biophys Res Commun 4 —6. Citation: Sousa ESA, Queiroz LAD, Guimarães JPT, Pantoja KC, Barros RS, Epiphanio S and Martins JO The influence of high glucose conditions on macrophages and its effect on the autophagy pathway. Received: 23 December ; Accepted: 13 March ; Published: 12 April Copyright © Sousa, Queiroz, Guimarães, Pantoja, Barros, Epiphanio and Martins.

This is an open-access article distributed under the terms of the Creative Commons Attribution License CC BY. The use, distribution or reproduction in other forums is permitted, provided the original author s and the copyright owner s are credited and that the original publication in this journal is cited, in accordance with accepted academic practice.

No use, distribution or reproduction is permitted which does not comply with these terms. Martins, martinsj usp. Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.

Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. Top bar navigation.

About us About us. Who we are Mission Values History Leadership Awards Impact and progress Frontiers' impact Progress Report All progress reports Publishing model How we publish Open access Fee policy Peer review Research Topics Services Societies National consortia Institutional partnerships Collaborators More from Frontiers Frontiers Forum Press office Career opportunities Contact us.

Sections Sections. About journal About journal. Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office. ORIGINAL RESEARCH article Front. This article is part of the Research Topic Emerging Talents in Inflammation: View all 6 articles.

The influence of high glucose conditions on macrophages and its effect on the autophagy pathway. Emanuella S. Sousa 1 Luiz A. Queiroz 1 João P. Guimarães 1 Kamilla C. Pantoja 1 Rafael S. Barros 1 Sabrina Epiphanio 2 Joilson O.

x PubMed Abstract CrossRef Full Text Google Scholar. Keywords: inflammation, diabetes mellitus, hyperglycemia, autophagy, macrophages Citation: Sousa ESA, Queiroz LAD, Guimarães JPT, Pantoja KC, Barros RS, Epiphanio S and Martins JO The influence of high glucose conditions on macrophages and its effect on the autophagy pathway.

Edited by: Eva Turley , Lawson Health Research Institute, Canada. Reviewed by: Zsuzsa Szondy , University of Debrecen, Hungary Renjun Gu , Nanjing University of Chinese Medicine, China.

Mindful eating tips Diabetology volume 15 Hypwrglycemia, Article number: 82 Cite this article. Metrics details. Ahd Erratum to this article was published on Hyperglycemia and inflammation February Hyperglycemia is acknowledged as a Amino acid turnover condition Hyperglucemia a major cause of vascular damage. Nevertheless, we have previously described that high glucose only promotes inflammation in human vascular cells previously primed with pro-inflammatory stimuli, such as the cytokine interleukin IL 1β. Here, we aimed to identify the cellular mechanisms by which high glucose exacerbates the vascular inflammation induced by IL1β. Cultured human aortic smooth muscle cells HASMC and isolated rat mesenteric microvessels were treated with IL1β in medium containing 5.

Author: Gulkree

3 thoughts on “Hyperglycemia and inflammation

  1. Ich entschuldige mich, aber meiner Meinung nach irren Sie sich. Es ich kann beweisen. Schreiben Sie mir in PM, wir werden reden.

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com